Company / Assets per Share
Seres Therapeutics, Inc. Assets per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$15.98
FY2025
5-year range
$2.79 / $15.98
FY2021-FY2025
Trend
+473.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +474% YoY in FY2025, a notable deviation from the 9-year average annual change of +37%.
Based on SEC 10-K filings.
15.98 in FY2025 with a 10-year CAGR of -6.6%.
Improved from $3.80 to $15.98 over the past 3 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +61.5%
- 5-Year CAGR
- +26.7%
- 10-Year CAGR
- -6.6%
Key checks
Key Insights
- In FY2025, assets per share increased 473.6% year-over-year.
- Peak assets per share was recorded in FY2015.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.98 | +473.6% |
| FY2023 | $2.79 | -26.6% |
| FY2022 | $3.80 | -2.2% |
| FY2021 | $3.88 | -20.6% |
| FY2020 | $4.89 | +51.1% |
| FY2019 | $3.24 | +9.0% |
| FY2018 | $2.97 | -36.8% |
| FY2017 | $4.70 | -32.7% |
| FY2016 | $6.98 | -77.8% |
| FY2015 | $31.48 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026